OMNISCAN is a Intravenous Injection in the Human Prescription Drug category. It is labeled and distributed by Ge Healthcare Inc.. The primary component is Gadodiamide.
Product ID | 0407-0690_2a6abafc-4d41-4f23-9507-689793bbe9f4 |
NDC | 0407-0690 |
Product Type | Human Prescription Drug |
Proprietary Name | OMNISCAN |
Generic Name | Gadodiamide |
Dosage Form | Injection |
Route of Administration | INTRAVENOUS |
Marketing Start Date | 2010-06-01 |
Marketing Category | NDA / NDA |
Application Number | NDA020123 |
Labeler Name | GE Healthcare Inc. |
Substance Name | GADODIAMIDE |
Active Ingredient Strength | 287 mg/mL |
Pharm Classes | Magnetic Resonance Contrast Activity [MoA],Paramagnetic Contrast Agent [EPC] |
NDC Exclude Flag | N |
Listing Certified Through | 2020-12-31 |
Marketing Start Date | 2010-06-01 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | NDA |
Application Number | NDA022066 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2007-10-02 |
Marketing End Date | 2011-04-06 |
Marketing Category | NDA |
Application Number | NDA020123 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | ML |
Marketing Start Date | 2002-04-19 |
Marketing Category | NDA |
Application Number | NDA022066 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | ML |
Marketing Start Date | 2007-10-02 |
Marketing Category | NDA |
Application Number | NDA020123 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | ML |
Marketing Start Date | 2002-04-19 |
Marketing Category | NDA |
Application Number | NDA020123 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | ML |
Marketing Start Date | 2002-04-19 |
Marketing Category | NDA |
Application Number | NDA020123 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | ML |
Marketing Start Date | 2002-04-19 |
Marketing Category | NDA |
Application Number | NDA020123 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | ML |
Marketing Start Date | 2002-04-19 |
Marketing Category | NDA |
Application Number | NDA020123 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | ML |
Marketing Start Date | 2010-06-01 |
Marketing Category | NDA |
Application Number | NDA020123 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | ML |
Marketing Start Date | 2002-04-19 |
Marketing Category | NDA |
Application Number | NDA020123 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | ML |
Marketing Start Date | 2010-06-01 |
Marketing Category | NDA |
Application Number | NDA020123 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | ML |
Marketing Start Date | 2002-04-19 |
Marketing Category | NDA |
Application Number | NDA020123 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2002-04-19 |
Marketing End Date | 2013-09-25 |
Marketing Category | NDA |
Application Number | NDA020123 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | ML |
Marketing Start Date | 2010-06-01 |
Marketing Category | NDA |
Application Number | NDA020123 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | ML |
Marketing Start Date | 2010-06-01 |
Marketing Category | NDA |
Application Number | NDA020123 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | ML |
Marketing Start Date | 2010-06-01 |
Ingredient | Strength |
---|---|
GADODIAMIDE | 287 mg/mL |
SPL SET ID: | f9fd4805-cbc1-4bc7-955f-e5cd4e1b03bb |
Manufacturer | |
UNII |
NDC | Brand Name | Generic Name |
---|---|---|
0407-0690 | OMNISCAN | gadodiamide |
0407-0691 | OMNISCAN | gadodiamide |